New Horizon Pharmatech Private Limited
About New Horizon Pharmatech Private Limited
Data last updated:
New Horizon Pharmatech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 06 August 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U22122DL2002PTC116463.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Nirmala Kumari and Neelam Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at K – 28 T/F South Extension Part II, New Delhi, Delhi, India – 110049.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.39 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹1.79 Lakh (net margin -6.3%) and EBITDA of ₹1.18 Lakh (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
New Horizon Pharmatech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressK – 28 T/F South Extension Part II, New Delhi, Delhi, India – 110049
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of New Horizon Pharmatech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of New Horizon Pharmatech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of New Horizon Pharmatech Private Limited, buy the company report.
Financials of New Horizon Pharmatech Private Limited
FY 2025 filings availableNew Horizon Pharmatech Private Limited reported revenue of ₹28.39 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 140% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | -6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of New Horizon Pharmatech Private Limited, buy the company report.
Board of directors of New Horizon Pharmatech Private Limited
New Horizon Pharmatech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmala Kumari | Director | 06 Aug 2002 | 24 Years 2 Months | Current |
| Neelam Kumari | Director | 06 Aug 2002 | 24 Years 2 Months | Current |
Peer comparison
New Horizon Pharmatech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gur Sat Man Enterprises Private Limited | ₹28.62 Lakh (FY 2025) | -30.0% | Delhi, India | |||
| Ui Neill Brands Private Limited | ₹28.57 Lakh (FY 2024) | -87.0% | Bangalore, Karnataka, India | |||
| Moneyratna Gold and Jewellery Private Limited | ₹28.46 Lakh (FY 2025) | Alappuzha, Kerala, India | ||||
| Gannayak Trades Pvt Ltd | ₹28.45 Lakh (FY 2025) | 1.0% | Kolkata, West Bengal, India | |||
| Lakshmi Vishnu Resources Private Limited | ₹28.42 Lakh (FY 2025) | Cuttack, Odisha, India | ||||
| New Horizon Pharmatech Private Limitedthis company | ₹28.39 Lakh (FY 2025) | -₹1.79 Lakh | -6.3% | 8.0% | New Delhi, Delhi, India | |
| Avira Commercial Services (OPC) Private Limited | ₹28.36 Lakh (FY 2025) | 118.0% | Kalyan, Maharashtra, India | |||
| Hiemy Techdose Herbal Private Limited | ₹28.27 Lakh (FY 2023) | 100.0% | Delhi, India | |||
| Gempat Traders Private Limited | ₹28.25 Lakh (FY 2025) | -49.0% | Patna, Bihar, India | |||
| Venkateswara Trendy Wear Private Limited | ₹28.06 Lakh (FY 2025) | 25.0% | Amalapuram, Andhra Pradesh, India | |||
| Skyloc Dentec Private Limited | ₹27.99 Lakh (FY 2024) | -48.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of New Horizon Pharmatech Private Limited, buy the company report.
Auditor
New Horizon Pharmatech Private Limited is audited by WDK & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| WDK & ASSOCIATES | FY 2017 | 016389N |
Shareholding
The shareholding of New Horizon Pharmatech Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of New Horizon Pharmatech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving New Horizon Pharmatech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for New Horizon Pharmatech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for New Horizon Pharmatech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
New Horizon Pharmatech Private Limited has 4 board changes on record since 2002: 3 appointments and 1 cessation. The latest: Vinit Kumar ceased to be Director on 21 Sep 2013.
Frequently asked questions
New Horizon Pharmatech is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 06 August 2002 (24+ years old) and is registered under CIN U22122DL2002PTC116463.
New Horizon Pharmatech has 2 current directors:
- Nirmala Kumari - Director
- Neelam Kumari - Director
The latest financial statements of New Horizon Pharmatech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of New Horizon Pharmatech is U22122DL2002PTC116463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
New Horizon Pharmatech was incorporated on 06 August 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of New Horizon Pharmatech by revenue are Gur Sat Man Enterprises Private Limited, Ui Neill Brands Private Limited, Moneyratna Gold and Jewellery Private Limited, Gannayak Trades Pvt Ltd, Lakshmi Vishnu Resources Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Vinit Kumar ceased to be Director on 21 Sep 2013. Vinit Kumar was appointed as Director on 09 Jul 2004. Neelam Kumari was appointed as Director on 06 Aug 2002. New Horizon Pharmatech has 4 board changes on record in total.
The registered office of New Horizon Pharmatech is at K – 28 TF South Extension Part II, New Delhi, Delhi, India – 110049.
New Horizon Pharmatech operates in the trading industry, in the other wholesale segment.
The compliance status of New Horizon Pharmatech is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
New Horizon Pharmatech can be reached at its registered office: K – 28 TF South Extension Part II, New Delhi, Delhi, India – 110049.